SLC5A9 encodes SGLT5, a sodium-coupled transporter that facilitates the transport of specific sugars and metabolites across cellular membranes. The protein functions as an electrogenic Na+-coupled symporter with primary activity for D-mannose transport and possible secondary activity for D-fructose and D-glucose [UniProt]. SLC5A9 demonstrates tissue-specific expression patterns, with functional presence in airway epithelium where it participates in absorption of glucose metabolites and short-chain fatty acids 1. The transporter shows selective substrate recognition, exclusively binding sugar substrates with pyranose rings containing axial hydroxyl groups on carbon 2 [UniProt]. In disease contexts, SLC5A9 variants have been identified in proliferative diabetic retinopathy patients through whole exome sequencing, suggesting potential involvement in microvascular complications 2. The gene also shows contextual expression in certain cancer types, particularly kidney-pancreatic-colorectal tumors, indicating possible metabolic reprogramming roles 3. Additionally, rare variants in SLC5A9 have been associated with suicidal behaviors in American Indian populations, though the mechanistic relationship remains unclear 4. The transporter's role in cellular hexose transport and its tissue-specific distribution suggest importance in maintaining glucose homeostasis in specialized cellular environments.